137 related articles for article (PubMed ID: 8906029)
1. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
Murray TG; O'Brien JM; Steeves RA; Smith BJ; Albert DM; Cicciarelli N; Markoe AM; Tompkins DT; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1376-81. PubMed ID: 8906028
[TBL] [Abstract][Full Text] [Related]
3. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma.
Hayden BC; Murray TG; Cicciarelli N; Scott IU; Alexandridou A; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2002 Mar; 120(3):353-9. PubMed ID: 11879140
[TBL] [Abstract][Full Text] [Related]
5. Local carboplatin therapy in transgenic murine retinoblastoma.
Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
13. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
[TBL] [Abstract][Full Text] [Related]
14. Transgenic models of retinoblastoma: what they tell us about its cause and treatment.
Albert DM; Griep AE; Lambert PF; Howes KA; Windle JJ; Lasudry JG
Trans Am Ophthalmol Soc; 1994; 92():385-400; discussion 400-1. PubMed ID: 7886874
[No Abstract] [Full Text] [Related]
15. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
[TBL] [Abstract][Full Text] [Related]
16. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
[TBL] [Abstract][Full Text] [Related]
17. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
Gallie BL; Budning A; DeBoer G; Thiessen JJ; Koren G; Verjee Z; Ling V; Chan HS
Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
[TBL] [Abstract][Full Text] [Related]
19. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.
Marr BP; Dunkel IJ; Linker A; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):881-3. PubMed ID: 22328819
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Retinoblastoma: The Role of External Beam Radiotherapy.
Kim JY; Park Y
Yonsei Med J; 2015 Nov; 56(6):1478-91. PubMed ID: 26446627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
